📰 Technology Network News
Page 75 - Technology Network News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technology Network. Real-time updates on events, politics, business and more.
May 31, 2023
A study has highlighted how some people may become HIV-free after receiving a stem cell transplant.
May 31, 2023
Clean hydrogen could not only propel vehicles with no emitted pollutants but also help decarbonize industrial processes.
May 31, 2023
Becker Capital Management Inc. boosted its stake in shares of IMAX Co. (NYSE:IMAX – Get Rating) by 3.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 241,107 shares of the company’s stock after buying an additional 7,880 shares during […]
May 31, 2023
Researchers decode the correlation between dietary protein intake and improved metabolic health in mice.
May 31, 2023
The Covid pandemic shutdowns in South Asia greatly reduced the concentration of short-lived cooling particles in the air, while the concentration of long-lived greenhouse gases was barely affected.
May 30, 2023
A case study highlights the world’s second person known to have an extreme resilience to a rare genetic form of early onset Alzheimer’s disease.
May 30, 2023
A study has found DNA evidence of the plague in 4,000-year-old skeletal remains, the oldest evidence of the plague in Britain to date.
May 27, 2023
IMAX (NYSE:IMAX – Get Rating) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday. A number of other research analysts also recently issued reports on the company. JPMorgan Chase & Co. upped their price target on IMAX from $16.00 to $19.00 and […]
May 27, 2023
Shares of IMAX Co. (NYSE:IMAX – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eleven research firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the […]
May 26, 2023
Data from a Mount Sinai-led phase 3 trial published today in <i>The New England Journal of Medicine</i> show that upadacitinib, a breakthrough, once-daily oral medication, helps patients achieve and maintain clinical and endoscopic remission.